Vision & Mission
R & D Centers
Patents & Intellectual Property
Environmental Health And Safety
Team up with the best for your generics
Biophore filed an US DMF (Type II US DMF) for the product Prochlorperazine (Base) on 05-June-17. US DMF # 31496 is available for reference to ANDA.
Biophore featured in the Silicon Review Magazine’s special issue of “ 30 Best tech companies – 2017” Link :
Biophore filed an US DMF for Tavaborole Biophore filed Type II US DMF for the product tavaborole, anti-fungal used in treatment of onchomycoses of toe nails. Biophore has a novel process and has filed an US Patent for the same. API is readily available for customers to meet the US P- IV timeline.
Biophore filed an US DMF (Type II US DMF) for the product Chlorpromazine on 19-Jun-17. US DMF # 31479 is available for reference to ANDA.
Biophore filed US DMF for Indigo Carmine (indigotindisulfonate sodium). Biophore filed a Type II US DMF for the product indigotindisulfonate sodium, a diagnostic agent used in kidney function test. Completeness assessment of the product is complete.
Biophore Invests into its first fully owned Manufacturing Facility, to be functionally active from Q1 2018.
Biophore features in the Silicon Review's list of top 10 fastest growing pharmaceutical companies globally.